Sitapride D, Dapagliflozin/ Sitagliptin

Dapagliflozin is used in the treatment of type 2 diabetes which helps to control the amount of sugar in the blood.

Dapagliflozin is known as a sodium-glucose cotransporter 2 (SGLT2) inhibitor. Dapagliflozin reduces the levels of sugar the body absorbs and increases the levels of sugar that leaves the body in the urine, however Dapagliflozin should be used together with regular exercise and the control of diet.

Patients who take Dapagliflozin may suffer from such side effects;

Nausea,
Frequent urge to urinate,
Increased thirst,
Urinary tract infection,
Symptoms of hypoglycaemia: feeling shaky or anxious,
Sweating,
Looking pale,
Feeling hungry,
Feeling that your heart is pounding (palpitations),
Feeling dizzy
Hypoglycaemia (Low blood sugar level) in combination with insulin or sulphonylurea,
Genital fungal infection

Sitagliptin is used in the treatment of type 2 diabetes mellitus which is also known as non-insulin-dependent diabetes (NIDDM).

Sitagliptin is known as a dipeptidyl peptidase 4 inhibitor. Sitagliptin operates by reducing the amount of glucagon and increases the amount of insulin produced by the pancreas to coltrol the blood sugar levels in the body. Glucagon causes the liver to produce more sugar, so by Sitagliptin reducing the amount of glucagon in the body, this also helps to reduce the levels of glucose in the blood.

Patients who take Sitagliptin may suffer from such side effects;

Headaches,
Mild nausea
Upset stomach,
Diarrhoea,
Constipation,
Headache,
Upper respiratory tract infection,
Hypoglycaemia (Low blood sugar level),
Nasopharyngitis,
Runny nose,
sore throat,
Joint or muscle pain